1. Hong Kong Chinese Medicine Clinical Study Centre, School of Chinese Medicine, Hong Kong Baptist University, Hongkong, 999077, P.R.China
2. Key Laboratory of Chinese Internal Medicine of Ministry of Education, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, P.R.China
3. Chinese Evidence-based Medicine Center, West China Hospital, Sichuan University, Chengdu, 610041, P.R.China
Sharing clinical trial data can increase the transparency of clinical trials, improve the authenticity of clinical trials. The current clinical research data transparency requirements are not satisfied, and it is still difficult to create an environment in which the sharing of deidentified data becomes the norm. The article has analyzed various concerns voiced about data sharing and proposed solutions in data ownership, technology, implementation, and legal issues systematically, calling for clinical trial data sharing in order to promote transparency of clinical trials, looking forward to minimizing the risks and maximizing the benefits of data sharing.
Vickers AJ. Whose data set is it anyway? Sharing raw data from randomized trials. Trials, 2006 16, 7: 15.
Food and Drug Administration Amendments Act of 2007. Available at: https://www.fda.gov/RegulatoryInformation/LawsEnforcedbyFDA/SignificantAmendmentstotheFDCAct/FoodandDrugAdministrationAmendmentsActof2007/ucm095442.
World Health Organization (WHO). WHO statement on public disclosure of clinical trial results. Geneva: WHO, 2015. Available at: http://www.who.int/ictrp/results/WHO_Statement_results_reporting_clinical_trials.pdf.
China Food and Drug Administration (CFDA). Announcements about clinical trial data self- inspection and verification. 2015. http://www.sda.gov.cn/WS01/CL1278/124800.html (assessed,
European Medicines Agency (EMA). Opening up clinical data on new medicines. Available at: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/10/news_detail_002624.jsp&mid=WC0b01ac058004d5c1.
Taichman D B, Sahni P, Pinborg A, et al. Data sharing statements for clinical trials. BMJ, 2017, 357: j2372.
Research Councils UK (RCUK). Common principles on data policy. Available at: http://www.rcuk.ac.uk/research/datapolicy/.
Public Library of Science (PLOS). Data availability. Available at: http://journals.plos.org/plosmedicine/s/data-availability#locacceptable-data-sharing-methods.
Loder E, Groves T. The BMJ requires data sharing on request for all trials. BMJ, 2015, 350: h2373.
Medical Research Council (MRC). Policies and guidance for researchers. Available at: https://www.mrc.ac.uk/research/policies-and-guidance-for-researchers/.
Institute of Medicine (IOM). Discussion framework for clinical trial data sharing: guiding principles, elements, and activities. Available at: https://www.nap.edu/catalog/18610/discussion-framework-for-clinical-trial-data-sharing-guiding-principles-elements.
Bian ZX, Wu TX. Legislation for trial registration and data transparency. Trials, 2010, 11(1): 64.
Song F, Parekh S, Hooper L, et al. Dissemination and publication of research findings: an updated review of related biases. Health Technol Assess, 2010, 14(8): 1-193.
Dowsett SA, Van Campen LE, Bednar LA. Developing good scientific publishing practices: one pharmaceutical company's perspective. Curr Med Res Opin, 2010, 26(6): 1249-1254.
The University of Utah. Ownership, intellectual property, and governance considerations for academic research data. Available at: https://www.slideshare.net/RebekahCummings/ownership-intellectual-property-and-governance-considerations-for-academic-research-data.